Yoichiro Kino

1.1k total citations
42 papers, 750 citations indexed

About

Yoichiro Kino is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Yoichiro Kino has authored 42 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 13 papers in Immunology and 11 papers in Infectious Diseases. Recurrent topics in Yoichiro Kino's work include Influenza Virus Research Studies (15 papers), Herpesvirus Infections and Treatments (14 papers) and Respiratory viral infections research (7 papers). Yoichiro Kino is often cited by papers focused on Influenza Virus Research Studies (15 papers), Herpesvirus Infections and Treatments (14 papers) and Respiratory viral infections research (7 papers). Yoichiro Kino collaborates with scholars based in Japan, United States and United Kingdom. Yoichiro Kino's co-authors include Yoshihiro Kawaoka, Ken Fujii, Gabriele Neumann, Ryoichi Mori, Kohji Ueda, Masashi Sakaguchi, Yoshinobu Hayashi, Ryuichi Sakamoto, Nobuya Ohtomo and Kenji Okada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

Yoichiro Kino

41 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoichiro Kino Japan 17 479 285 156 121 115 42 750
Morag Ferguson United Kingdom 19 352 0.7× 377 1.3× 117 0.8× 100 0.8× 224 1.9× 32 947
Ken Lemon United Kingdom 18 601 1.3× 337 1.2× 142 0.9× 37 0.3× 99 0.9× 29 822
Ming Qiao Australia 19 554 1.2× 423 1.5× 122 0.8× 303 2.5× 160 1.4× 36 1.1k
C. A. Kraaijeveld Netherlands 19 465 1.0× 435 1.5× 268 1.7× 320 2.6× 172 1.5× 64 1.2k
Branda Hu United States 17 464 1.0× 565 2.0× 141 0.9× 190 1.6× 168 1.5× 33 1.1k
Sally Mossman United States 15 597 1.2× 263 0.9× 448 2.9× 115 1.0× 185 1.6× 20 1.0k
Mohammed Alsharifi Australia 16 395 0.8× 263 0.9× 523 3.4× 98 0.8× 123 1.1× 34 957
Caroline Obert United States 12 559 1.2× 248 0.9× 101 0.6× 163 1.3× 275 2.4× 17 978
Peter McWaters Australia 14 216 0.5× 173 0.6× 263 1.7× 39 0.3× 121 1.1× 17 697

Countries citing papers authored by Yoichiro Kino

Since Specialization
Citations

This map shows the geographic impact of Yoichiro Kino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Kino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Kino more than expected).

Fields of papers citing papers by Yoichiro Kino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Kino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Kino. The network helps show where Yoichiro Kino may publish in the future.

Co-authorship network of co-authors of Yoichiro Kino

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichiro Kino. A scholar is included among the top collaborators of Yoichiro Kino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichiro Kino. Yoichiro Kino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohno, Marumi, Toshiki Sekiya, Naoki Nomura, et al.. (2022). Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques. Vaccine. 41(3). 787–794. 2 indexed citations
2.
Hayashida, Kenshi, et al.. (2020). Clinical phase II and III studies of an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform. Influenza and Other Respiratory Viruses. 14(5). 551–563. 4 indexed citations
3.
Nagao, Mizuho, Takao Fujisawa, Toshiaki Ihara, & Yoichiro Kino. (2015). Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine–associated anaphylaxis. Journal of Allergy and Clinical Immunology. 137(3). 861–867. 32 indexed citations
4.
Ezzikouri, Sayeh, Tomohiro Nishimura, Michinori Kohara, et al.. (2014). Inhibitory effects of Pycnogenol® on hepatitis C virus replication. Antiviral Research. 113. 93–102. 19 indexed citations
6.
Okada, Kenji, et al.. (2013). Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV). The Journal of Infectious Diseases. 208(2). 275–283. 28 indexed citations
7.
Sakamoto, Ryuichi, et al.. (2012). Development of a recombinant vaccine against infectious coryza in chickens. Research in Veterinary Science. 94(3). 504–509. 14 indexed citations
8.
Sakamoto, Ryuichi, Yoichiro Kino, & Masashi Sakaguchi. (2011). Development of a Multiplex PCR and PCR-RFLP Method for Serotyping of Avibacterium paragallinarum. Journal of Veterinary Medical Science. 74(2). 271–273. 36 indexed citations
9.
Kimachi, Kazuhiko, et al.. (2009). A prime–boost vaccination of mice with heterologous H5N1 strains. Vaccine. 27(23). 3121–3125. 10 indexed citations
10.
Kimachi, Kazuhiko, Yoichiro Kino, Seiichi Harada, et al.. (2009). Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection. Microbiology and Immunology. 54(2). 81–88. 17 indexed citations
12.
Horimoto, Taisuke, Shin Murakami, Yukiko Muramoto, et al.. (2007). Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology. 366(1). 23–27. 44 indexed citations
13.
Hammar, Lena Marmstål, et al.. (2006). Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines. Virus Research. 121(2). 152–160. 12 indexed citations
14.
Okada, Kenji, Kohji Ueda, Kazunori Morokuma, et al.. (2004). Seroepidemiologic Study on Pertussis, Diphtheria, and Tetanus in the Fukuoka Area of Southern Japan: Seroprevalence among Persons 0 - 80 Years Old and Vaccination Program. Japanese Journal of Infectious Diseases. 57(2). 67–71. 20 indexed citations
15.
Nakamura, Hideki, Kenshi Hayashida, Keishin Sugawara, et al.. (2003). Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine. Vaccine. 21(31). 4519–4526. 31 indexed citations
16.
Sugawara, Keishin, et al.. (2002). Development of Vero Cell-Derived Inactivated Japanese Encephalitis Vaccine. Biologicals. 30(4). 303–314. 67 indexed citations
17.
Kino, Yoichiro, et al.. (1996). Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion. Journal of Virological Methods. 56(2). 161–171. 23 indexed citations
18.
Kino, Yoichiro, et al.. (1985). Passive Immunization of Mice with Monoclonal Antibodies to Glycoprotein gB of Herpes Simplex Virus. Microbiology and Immunology. 29(2). 143–149. 26 indexed citations
19.
Hayashi, Yoshinobu, et al.. (1982). Mechanism of Antibody‐Mediated Protection against Herpes Simplex Virus Infection in Athymic Nude Mice: Requirement of Fc Portion of Antibody. Microbiology and Immunology. 26(6). 497–509. 33 indexed citations
20.
Kino, Yoichiro, et al.. (1982). Dissemination of Herpes Simplex Virus in Nude Mice after Intracutaneous Inoculation and Effect of Antibody on the Course of Infection. Journal of General Virology. 63(2). 475–479. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026